Latest news from the Science Center, our resident companies and the innovation ecosystem.
June 13, 2018 | Resident & Alumni News
Meet the Disruptors: Lia Diagnostics
In a now decade-and-a-half old episode of Friends, Phoebe finds a positive pregnancy test in the bathroom trash and assumes it belongs to friend Monica, who just so happens to be getting married that day. Phoebe quickly spreads the news, and Monica’s soon-to-be-husband Chandler catches wind. He flees with a case of cold feet, but returns just in time to marry Monica, having come to terms with and even grown excited about being a father.
Philly startup HeavyWater gets acquired by Florida-based Black Knight
A publicly-traded data analytics company in Jacksonville, Fla., saw value in a Philly startup called HeavyWater — makers of an artificial intelligence platform aimed at mortgage processing. Mortgage services firm Black Knight announced Monday it acquired University City’s HeavyWater, which has a team of 14 based out of the Innovation Center @3401.
Meet AIVA: Black Knight buys Philly artificial-intelligence start-up
Black Knight Inc., a Jacksonville-based firm with a $1 billion in annual sales analyzing mortgages for large banks, says it has agreed to purchase HeavyWater, a University City Science Center-based, two-year-old firm that is developing AIVA (“Ava,”) an “artificial intelligence and machine learning” mortgage lending system to speed loan approvals, from founder Soofi Safavi.
Integral Molecular Celebrates Epitope Mapping Milestone of 1,000 Epitopes
Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, celebrates a milestone of mapping 1,000 epitopes for customers, collaborators, and the NIH.
Integral Molecular’s MPS Antibody Discovery Platform Yields Therapeutic Assets for Oncology and Metabolic Syndrome
Integral Molecular, the industry leader in membrane protein antibody discovery, announces the development of antibody assets targeting membrane proteins important in oncology (Claudin 6) and metabolic syndrome (GLUT4 and CB1). These therapeutic assets are among the first released in a pipeline of antibodies being isolated with the MPS Discovery Engine®, which is tailored for the discovery of rare, functional antibodies against complex membrane protein targets.
CIC Philadelphia Welcomes General Manager, Ravid Butz
CIC Philadelphia is excited to welcome new General Manager, Ravid Butz. Ravid brings over 20 years in business management to CIC Philadelphia, which is slated to open this fall at 3675 Market Street in uCity Square.
Robots in the operating room are on the rise. Led by the Da Vinci surgical robot, these machines improve surgeons’ dexterity in such intricate tasks as separating tumors from the voice box or removing the prostate. But Mohammad Abedin-Nasab, a professor of biomedical engineering at Rowan University, is working on a different kind of surgery. His robot, called Robossis, could help surgeons perform the tricky operation of realigning a broken femur, the bone between the knee and the hip.
Imagine: animal testing that is as good for animals as it is for humans. Most of us know that medical animal testing goes on, and we accept it as the bleak price we pay for the medical miracles that will hopefully save our parents, our children, ourselves, when a terrible disease takes hold.
Group K Diagnostics Wins Mid Atlantic Bio Angels’ “Best of the Best” at 1st Pitch Life Science Competition
Mid-Atlantic Bio Angels (MABA) announces today that Group K Diagnostics (Group K), a Philadelphia-based diagnostics company developing a multi-test modular point of care diagnostic platform, was named “Best of the Best” at MABA's 1st Pitch Life Science event held on December 13, 2017 at the Alexandria Center in New York.
When Benjamin Lewis was in veterinary school at the University of Pennsylvania, he worked both in vets’ offices caring for sick animals, and in research labs where healthy animals were injected with diseases for drug testing. In the same day, Lewis might see a dog suffering naturally from the same disease that he had seen injected into a healthy animal in the name of medical research a few hours before.